Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
About NEUBASE THERAPEUTICS, INC
Sector
Headquarters
Pittsburgh
Founded
2002
Website
FIGI
BBG00Z1WHW83
NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange NEUBASE THERAPEUTICS, INC stocks are traded under the ticker NBSE.
Yes, you can track NEUBASE THERAPEUTICS, INC financials in yearly and quarterly reports right on TradingView.
NEUBASE THERAPEUTICS, INC is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
No, NBSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NBSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUBASE THERAPEUTICS, INC stock right from TradingView charts — choose your broker and connect to your account.